Status:
WITHDRAWN
Extended Release (ER) Niacin/Laropiprant Add on Study (0524A-082)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Dyslipidemia
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to test the effect of MK0524A (niacin (+) laropiprant) on lowering bad cholesterol and raising good cholesterol.
Eligibility Criteria
Inclusion
- Patients 18 years of age or older and on a stable dose of lipid therapy
Exclusion
- Patients lipid level is outside the recommended range
- Patients that are HIV positive
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00664287
Start Date
September 1 2008
Last Update
April 9 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.